Alex Keeton is the Executive Director of the Biosimilars Council and leads the policy team at the Association for Accessible Medicines (AAM). A healthcare policy and government affairs leader with extensive experience on issues related to health insurance and prescription drugs, he most recently served as Vice President, Pharmacy Care Services, at UnitedHealth Group, where he shaped enterprise strategy around drug affordability and pharmacy benefits.
Previously, Alex held senior policy roles at the Biotechnology Innovation Organization and America’s Health Insurance Plans, providing research, analysis, and advocacy on complex health policy issues. Alex holds a MPP in Health Policy from The George Washington University and a BA in Communications, Law, Economics, and Government from American University.
